ArticleBiometrical journal. Biometrische Zeitschrift2023

A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages.

José L Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.